SCHEMBL13426

SCHEMBL13426

Cc1noc(-c2ccc(Br)cc2)c1CC(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
RAB9A P51151 3/20 0.37
TP53 P04637 2/20 0.37
NPC1 O15118 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPK1 P28482 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37
TRPV1 Q8NER1 1/20 0.37
PTPN1 P18031 1/20 0.37
MAPT P10636 1/20 0.37
P2RX7 Q99572 1/20 0.36
HTT P42858 1/20 0.36
CACNA1F O60840 1/20 0.36
ABCB1 P08183 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1279 0.87 CYP1A2 (0.43) CYP1A2CYP3A4CYP2C9CYP2C19TDP1
SCHEMBL13455 0.86 L3MBTL1 (0.45) NPC1SMN1; SMN2ALDH1A1FFAR4PTPN1
SCHEMBL3829 0.85 P2RX7 (0.42) CYP1A2CYP3A4CYP2C9CYP2C19TDP1
SCHEMBL1555 0.82 HTT (0.45) LMNACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL6483 0.80 CYP1A2 (0.43) LMNACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1683 0.80 CYP1A2 (0.43) CYP1A2CYP3A4CYP2C9CYP2C19TDP1
SCHEMBL10078633 0.79 LPAR1 (0.38) CYP1A2CYP3A4CYP2C9CYP2C19TDP1
SCHEMBL1185 0.79 CYP1A2 (0.44) LMNACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL18597812 0.79 CYP1A2 (0.44) LMNACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1652 0.78 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C9CYP2C19TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-B1 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS INC (US) 2017-03-08 EP disclosed
WO-2011041462-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed